Clinical trial
Chloroquine Alone or in Combination for Malaria in Children in Malawi
NCT00379821 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00379821 |
|---|---|
| Title | Chloroquine Alone or in Combination for Malaria in Children in Malawi |
| Official title | A Longitudinal Study of Chloroquine as Monotherapy or in Combination With Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria in Children in Blantyre, Malawi |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Plasmodium Falciparum Infection |
| Intervention type | Drug |
| Interventions | Atovaquone-proguanil, Artesunate, Azithromycin, Chloroquine |
| Enrollment | 640 |
| Start date | Feb 1, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | Sep 1, 2012 |
| First posted | Sep 25, 2006 |
| Last update posted | Aug 11, 2014 |
| Countries | Malawi |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: